Searchable abstracts of presentations at key conferences in endocrinology

ea0056oc7.5 | Genomic and clinical aspects of endocrine tumours | ECE2018

Randomized trial comparing phenoxybenzamine and doxazosine for preoperative treatment of patients with a pheochromocytoma (PRESCRIPT)

Buitenwerf E , Osinga TE , Timmers HJLM , Lenders JWM , Feelders RA , Eekhoff EMW , Haak HR , Corssmit EPM , Bisschop PHLT , Valk GD , GrooteVeldman R , Dullaart RPF , Links TP , Voogd MF , Wietasch JKG , Kerstens MN

Background: Administration of α-adrenergic receptor antagonists is recommended before resection of a pheochromocytoma (PCC) in order to prevent perioperative cardiovascular complications. For this purpose either phenoxybenzamine (PXB) or doxazosin (DOX) is commonly prescribed. We conducted the first randomized controlled trial comparing the efficacy of PXB and DOX in controlling perioperative hemodynamics in patients undergoing PCC resection (ClinicalTrials.gov:NCT0137989...